Thursday, December 12 2024 | 13 h 03 min | News
Bausch + Lomb Corporation announced that an affiliate has acquired Elios Vision, Inc, developer of the ELIOS™ procedure, the first clinically...
Read More
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Learn More
Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more
Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more
Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.
Read more
The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.
Read more
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Learn More Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read More Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read More Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.
Read More The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.
Read More
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Learn More Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.
Read more The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.
Read more AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Learn More Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more Transitions Optical has unveiled the finalists for its annual Transitions® Innovation Awards program, which recognizes individuals and organizations from North America who have shown unparalleled commitment to implementing innovative programs and technologies over the past year.
Read more The Optical Women’s Association (OWA) announces an OWA Global Event at MIDO in Milan, as expansion plans continue to reach out to women in the optical industry internationally.
Read more
